Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jane V. Harper
Observed names:
Harper, Jane,
Jane Harper,
Jane V Harper
Institution:
Immunocore (United Kingdom)
Observed institutions:
Rutherford Appleton Laboratory,
Science and Technology Facilities Council,
Churchill Hospital,
University of Oxford,
Immunocore (United Kingdom),
CRUK/MRC Oxford Institute for Radiation Oncology,
Central Laser Facility,
University of Reading,
Medical Research Council
show all 9
OpenAlex ID:
A5109471232
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
2013
·
Gerald P. Linette
, Edward A. Stadtmauer
, et al.
·
Blood
·
1,208
Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells
2013
·
Brian J. Cameron
, Andrew B. Gerry
, et al.
·
Science Translational Medicine
·
703
Monoclonal TCR-redirected tumor cell killing
2012
·
Nathaniel Liddy
, Giovanna Bossi
, et al.
·
Nature Medicine
·
329
Induction and quantification of γ-H2AX foci following low and high LET-irradiation
2006
·
Emma L. Leatherbarrow
, Jane V. Harper
, et al.
·
International Journal of Radiation Biology
·
194
The dynamics of Ku70/80 and DNA-PKcs at DSBs induced by ionizing radiation is dependent on the complexity of damage
2012
·
Pamela Reynolds
, Jennifer A. Anderson
, et al.
·
Nucleic Acids Research
·
145
PDF
Biochemical Kinetics Model of DSB Repair and Induction of γ-H2AX Foci by Non-homologous End Joining
2008
·
Francis A. Cucinotta
, Janice M. Pluth
, et al.
·
Radiation Research
·
127
Synchronization of Cell Populations in G1/S and G2/M Phases of the Cell Cycle
2004
·
Jane V. Harper
·
Humana Press eBooks
·
119
Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
2008
·
Remko Prevo
, Eric Deutsch
, et al.
·
Cancer Research
·
118
PDF
Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor
2015
·
Joost H van den Berg
, Raquel Gomez-Eerland
, et al.
·
Molecular Therapy
·
112
The Mammalian Cell Cycle: An Overview
2004
·
Jane V. Harper
, Gavin Brooks
·
Humana Press eBooks
·
112
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
2018
·
Jane Harper
, Katherine J. Adams
, et al.
·
PLoS ONE
·
87
PDF
Radiation induced DNA DSBs: Contribution from stalled replication forks?
2010
·
Jane V. Harper
, Jennifer A. Anderson
, et al.
·
DNA repair
·
84
Participation of DNA-PKcs in DSB Repair after Exposure to High- and Low-LET Radiation
2010
·
Jennifer A. Anderson
, Jane V. Harper
, et al.
·
Radiation Research
·
55
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide–HLA Complex
2020
·
Charlotte H Coles
, Rachel M Mulvaney
, et al.
·
The Journal of Immunology
·
52
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle
2003
·
Gavin Brooks
, Xue-Mei Yu
, et al.
·
Journal of Pharmacy and Pharmacology
·
44
Induction of Persistent Double Strand Breaks Following Multiphoton Irradiation of Cycling and G1‐arrested Mammalian Cells—Replication‐induced Double Strand Breaks
2008
·
Jane V. Harper
, Pamela Reynolds
, et al.
·
Photochemistry and Photobiology
·
30
Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients
2025
·
Ramon Staeger
, Aizhan Tastanova
, et al.
·
Journal of Clinical Investigation
·
16
PDF
Abstract 3295: Vitiligo and other clinical melanocyte-related adverse events following tebentafusp (IMCgp100) exposure in patients with uveal melanoma
2020
·
Marlana Orloff
, Joseph J. Sacco
, et al.
·
Cancer Research
·
5
Abstract 5572: IMC-F106C, a novel and potent immunotherapy approach to treat PRAME expressing solid and hematologic tumors
2020
·
Sylvie Moureau
, Alessio Vantellini
, et al.
·
Cancer Research
·
5
Abstract 3525: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma
2012
·
Namir J. Hassan
, Katherine Adams
, et al.
·
Cancer Research
·
4
ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing
2015
·
Zoe Donnellan
, Giovanna Bossi
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
PDF
Abstract 1238: IMCgp100: a novel bispecific biologic for the treatment of malignant melanoma.
2013
·
Mark Middleton
, Jeff Evans
, et al.
·
Cancer Research
·
2
Biochemical Kinetics Model of DSB Repair and GammaH2AX FOCI by Non-homologous End Joining
2007
·
Francis A. Cucinotta
, Janice M. Pluth
, et al.
·
NASA Technical Reports Server (NASA)
·
2
624 IFNγ secreted by tebentafusp (IMCgp100)-redirected T cells inhibits expression of melanin synthesis pathway genes in healthy melanocytes
2020
·
Mariantonella Vardeu
, David Depoil
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Abstract 2271: Tebentafusp recognition of melanoma cells is restricted by HLA-A0201 presentation of a gp100 peptide
2020
·
David Cole
, Ross Robinson
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
43
Citation count:
3,560
H-index:
16
I10-index:
17
Year
Topic
Type